
Robots That Copy Scientists for Cell Therapy: Multiply Labs' Fred Parietti
Episode 25 of the Audrow Nash Podcast.
A bag of gene-edited cells can be worth about half a million dollars (Fred's range for a dose is roughly $400K to $2M), and today that work is still done by hand in clean rooms, over thousands of steps.
I talk with Fred Parietti, Co-founder and CEO of Multiply Labs, about robots that manufacture cell and gene therapies using the same instruments, reagents, and consumables the scientists use, why they train from video of scientists instead of teleoperation, and where a ~$30K humanoid fits in their plant (loading and unloading carts, not the science).
You'll like this interview if you're a roboticist curious about pharma, a founder picking high-value problems over pizza robots, or anyone who wants Fred's take on "infinite market" pitches and a robotics winter. The biology explainer (16:08–34:00) is the most technical stretch.
EPISODE LINKS
- Multiply Labs: https://www.multiplylabs.com
PODCAST LINKS
- Podcast Website: https://audrownashpodcast.com/
- YouTube: https://www.youtube.com/@audrow
- Apple Podcasts: https://podcasts.apple.com/us/podcast/audrow-nash-podcast/id1716486786
- Spotify: https://open.spotify.com/show/74jWpWiLwsasY2QHtDcl8I?si=6c92796bf9554162
TIMECODES
0:00 Cold open
0:53 Multiply Labs overview
7:17 Pharma robotics gap
16:08 Next-gen pharma
34:00 Multiply Labs automation
43:54 Deployment size
1:00:04 Thoughts on humanoids
1:10:01 Training process
1:21:39 High-value problems
1:24:37 Key takeaways
Otros episodios de "Audrow Nash Podcast"



No te pierdas ningún episodio de “Audrow Nash Podcast”. Síguelo en la aplicación gratuita de GetPodcast.








